American AIDS relief program saves lives globally

  • Article by: EDITORIAL , Washington Post
  • Updated: February 26, 2013 - 7:43 PM
hide

May 2012: Minnesota AIDS Walk at Minnehaha Park in Minneapolis.

Photo: Carlos Gonzalez, Star Tribune

CameraStar Tribune photo galleries

Cameraview larger

In the history of global public health, there has been nothing quite like it. Since 2003, Congress has appropriated more than $38 billion for the President’s Emergency Plan for AIDS Relief, known as PEPFAR — the largest global health initiative ever undertaken focused on a single disease.

Congress reauthorized the program for five years in 2008 and asked for a report card. Now, after four years of work, some 400 interviews and visits to 13 nations, the Institute of Medicine of the National Academy of Sciences has provided a 678-page examination of this incredibly ambitious program.

The verdict: PEPFAR has been “globally transformative,” a “lifeline” and credited around the world for “restoring hope” in the long, difficult struggle against HIV/AIDS, which has taken nearly 30 million lives over three decades. Furthermore, the program “has saved and improved the lives of millions.” It set big goals “and has met or surpassed many of them.”

One small statistic speaks volumes: As of September, the U.S. government has supported antiretroviral treatment for more than 5 million men, women and children. When the program began, there were plenty of doubts about whether HIV prevention, treatment and care could be scaled up in low- and moderate-income countries and make a difference.

In the 10 years since, PEPFAR has demonstrated that it could be done. In the next decade, the challenge will be to sustain it, and much work remains. The epidemic is still being driven by new HIV infections — about 2.5 million worldwide in 2011, or 7,000 new infections per day.

Treatment and care help those already afflicted, but prevention is the key to slowing the rate of new infections. Research has produced both hope for new prevention techniques, such as a major clinical trial that proved antiretroviral drugs can help protect the sexual partners of an infected person, and success in reducing infection rates through circumcision.

In the early years, PEPFAR’s prevention programs were considered too narrow. Now, the report notes, there has been a needed “evolution” toward broader efforts.

Another PEPFAR shift, already underway, is to move away from providing services directly — the kind of rapid action that brought such success in the early years — to helping countries fight HIV/AIDS on their own, in their existing health care systems.

  • get related content delivered to your inbox

  • manage my email subscriptions

ADVERTISEMENT

  • about opinion

  • The Opinion section is produced by the Editorial Department to foster discussion about key issues. The Editorial Board represents the institutional voice of the Star Tribune and operates independently of the newsroom.

  • Submit a letter or commentary
Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

 
Close